Table 1 from First-in-Human Dose-Escalation Study of Fianlimab, an Antilymphocyte Activation Gene-3 Antibody, with Cemiplimab in Patients with Advanced Malignancies Article Swipe

Nehal J. Lakhani , Kyriakos P. Papadopoulos , Melissa L. Johnson , Haeseong Park , Ding Wang , Timothy A. Yap , Afshin Dowlati , Robert G. Maki , Susanna V. Ulahannan , Filipa Lynce , Karen Kelly , Stephen K. Williamson , Jyoti Malhotra , Shuquan Chen , Ana Gonzalez Ortiz , Vladimir Jankovic , Anne Paccaly , Sheila Masinde , Jayakumar Mani , Israel Lowy , Giuseppe Gullo , Tasha N. Sims , Glenn S. Kroog · YOU? · · 2024 · Open Access · · DOI: https://doi.org/10.1158/1078-0432.28032358 · OA: W4405454318